Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated

Download (PDF)

Why has NICE said this?

NICE looks at how well treatments work in relation to how much they cost compared with other treatments available on the NHS.

Abiraterone was recommended because the benefits to patients justify its cost.